Gerstein HC, Miller ME, Byington RP, et al.;. Action to Control Cardiovascular Risk in Diabe- .... Silver Spring, MD, U.S. Food and. Drug Administration, 2016. 30.
DIABETES AND AGING
468
Diabetes Care Volume 40, April 2017
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006–2013
Kasia J. Lipska,1 Xiaoxi Yao,2,3 Jeph Herrin,4 Rozalina G. McCoy,2,3,5 Joseph S. Ross,6,7 Michael A. Steinman,8 Silvio E. Inzucchi,1 Thomas M. Gill,9 Harlan M. Krumholz,4,7 and Nilay D. Shah2,3,10
Diabetes Care 2017;40:468–475 | DOI: 10.2337/dc16-0985
OBJECTIVE
To examine temporal trends in utilization of glucose-lowering medications, glycemic control, and rate of severe hypoglycemia among patients with type 2 diabetes (T2DM). RESEARCH DESIGN AND METHODS
Using claims data from 1.66 million privately insured and Medicare Advantage patients with T2DM from 2006 to 2013, we estimated the annual 1) age- and sexstandardized proportion of patients who filled each class of agents; 2) age-, sex-, race-, and region-standardized proportion with hemoglobin A1c (HbA1c)